Polycythemia in the newborn: do asymptomatic babies need exchange transfusion?
Related Experiment Videos
M Singh1, P K Singhal, V K Paul
1Department of Pediatrics and Biostatistics, All India Institute of Medical Sciences, New Delhi.
Insights
Neonatal polycythemia, a condition of high hematocrit in newborns, occurred in 1.2% of infants. Postterm, large-for-dates, and small-for-dates infants faced higher risks, with comparable neurodevelopmental outcomes regardless of symptoms or treatment.
Area of Science:
- Neonatalogy
- Pediatric Hematology
Background:
- Neonatal polycythemia is characterized by elevated hematocrit levels in newborns.
- Risk factors and clinical manifestations require further investigation for effective management.
Purpose of the Study:
- To determine the incidence and risk factors of neonatal polycythemia.
- To analyze the clinical presentation and outcomes of polycythemic infants.
Main Methods:
- Screening of 2288 infants for hematocrit levels over 15 months.
- Comparison of polycythemia incidence across gestational age and birth weight categories.
- Clinical observation and neurodevelopmental assessment (MDI, PDI) of affected infants.
Main Results:
- Polycythemia incidence was 1.2% (27/2288).
- Postterm (3.4%), large-for-dates (2.2%), and small-for-dates (13.2%) infants had significantly increased risk compared to term and appropriate-for-dates infants.
- Symptomatic infants (jitteriness, respiratory distress, lethargy) had higher mean hematocrit (76.0) than asymptomatic ones (70.84).
- Partial exchange transfusion was performed for symptomatic cases; asymptomatic cases received no intervention.
- Neurodevelopmental indices (MDI, PDI) were comparable between symptomatic and asymptomatic groups.
Conclusions:
- Gestational age and birth weight are significant risk factors for neonatal polycythemia.
- While symptomatic polycythemia requires intervention, neurodevelopmental outcomes appear comparable between symptomatic and asymptomatic infants in this cohort.
Abstract:
A total of 2288 infants were screened for hematocrit over a period of 15 months. Polycythemia was diagnosed in 27 cases (1.2%). Preterm and term babies had more or less equal risk to develop polycythemia (1.5% and 1.1% respectively) while postterm infants had at least three times increased risk (3.4%) when compared to their term counterparts. Large-for-dates (LFDs) and small-for-dates (SFDs) infants had increased risk of manifesting polycythemia which was nearly four times (2.2%) and twenty-five times (13.2%) respectively, as compared to appropriate-for-dates (AFDs) babies (0.5%). About one-third of polycythemic infants had one or more symptoms. The most common symptoms observed was jitteriness (25.9%) followed by respiratory distress (14.8%) and lethargy (11.1%). The mean (+/- SD) hematocrit of symptomatic newborns (76.0 +/- 4.04) was found to be significantly higher (p less than 0.001) as compared to asymptomatic babies (70.84 +/- 2.73). Partial exchange transfusion with plasma was performed in all the symptomatic cases within 8 hours of onset of symptoms. No such intervention was performed in asymptomatic cases. On neurodevelopment follow-up, the development indices (MDI and PDI) of both asymptomatic and symptomatic cases were found to be comparable.